A research team from the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) discovered more efficient CRISPR-Cas9 variants that could be useful for gene therapy applications. By ...

New Early Access Express License provides streamlined, affordable access to foundational CRISPR/Cas9 intellectual property to ...

A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications. The approach, developed at Gladstone Institutes and UC ...

Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage ...

Using a CRISPR-based genetic screen, Cellecta recently identified, for a client, a class of proteins responsible for regulating gene expression of a genetic element present in the 5′-untranslated ...

A version of this Priestley Medal address will be presented at the American Chemical Society Spring 2026 meeting ...

-EU and UK filings completed in 2022; submissions validated by EMA and MHRA and the review procedure has begun as of January 2023- BOSTON & ZUG, Switzerland--(BUSINESS WIRE)--Vertex Pharmaceuticals ...

Functionally relevant changes to cellular genetic code were first observed by exposing cells to radiation or genotoxic chemicals to introduce random mutations. It was later shown that precise genome ...

Scientists have worked tirelessly to develop ever more precise and efficient CRISPR-Cas systems to reach the ultimate goal: safe and effective CRISPR-Cas-based medical treatments. Over the years, ...